Lexicon Pharmaceuticals
LXRX
LXRX
113 hedge funds and large institutions have $204M invested in Lexicon Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 115 → 113 (-2)
2.82% less ownership
Funds ownership: 100.86% → 98.04% (-2.8%)
54% less capital invested
Capital invested by funds: $445M → $204M (-$240M)
Holders
113
Holding in Top 10
3
Calls
$293K
Puts
$245K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.67M | |
| 3 | +$1.18M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$980K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$965K |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$5.43M | |
| 3 | -$2.07M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.96M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.84M |